These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21093021)

  • 1. Patient characteristics associated with allergen immunotherapy initiation and adherence.
    Hankin CS; Lockey RF
    J Allergy Clin Immunol; 2011 Jan; 127(1):46-8, 48.e1-3. PubMed ID: 21093021
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved patient adherence to subcutaneous allergen immunotherapy using a modified rush immunotherapy protocol.
    Teachout J; Vandegrift S; Schafer C; Uekert S; Gell K
    Ann Allergy Asthma Immunol; 2019 Mar; 122(3):347-349. PubMed ID: 30308317
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of adherence to allergen-specific immunotherapy.
    Senna G; Ridolo E; Calderon M; Lombardi C; Canonica GW; Passalacqua G
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):544-8. PubMed ID: 19823080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralymphatic immunotherapy.
    Senti G; Johansen P; Kündig TM
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):537-43. PubMed ID: 19680119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One hundred years of allergen immunotherapy: time to ring the changes.
    Durham SR; Leung DY
    J Allergy Clin Immunol; 2011 Jan; 127(1):3-7. PubMed ID: 21211638
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with non-adherence to specific allergen immunotherapy in management of respiratory allergy.
    Mahesh PA; Vedanthan PK; Amrutha DH; Giridhar BH; Prabhakar AK
    Indian J Chest Dis Allied Sci; 2010; 52(2):91-5. PubMed ID: 20578401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children's compliance with allergen immunotherapy according to administration routes.
    Pajno GB; Vita D; Caminiti L; Arrigo T; Lombardo F; Incorvaia C; Barberio G
    J Allergy Clin Immunol; 2005 Dec; 116(6):1380-1. PubMed ID: 16337474
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting compliance with allergen immunotherapy at a military medical center.
    More DR; Hagan LL
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):391-4. PubMed ID: 11991556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergen-specific immunotherapy--vaccination against allergy].
    Brygge T; Mosbech H
    Ugeskr Laeger; 2000 Jan; 162(4):524-7. PubMed ID: 10697458
    [No Abstract]   [Full Text] [Related]  

  • 10. Health economics of allergen-specific immunotherapy in the United States.
    Lockey RF; Hankin CS
    J Allergy Clin Immunol; 2011 Jan; 127(1):39-43. PubMed ID: 21211640
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and specific treatment for a global disease: allergen immunotherapy revisited.
    Kowalski ML
    Allergy; 2006 Jul; 61(7):791-5. PubMed ID: 16792575
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year).
    Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
    J Allergy Clin Immunol; 2006 Apr; 117(4):946-8. PubMed ID: 16630956
    [No Abstract]   [Full Text] [Related]  

  • 14. Montelukast might improve compliance with subcutaneous immunotherapy treatments in patients with allergic asthma.
    Vaughn MP
    J Allergy Clin Immunol; 2011 Jan; 127(1):286; author reply 286-7. PubMed ID: 20850867
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of allergen-specific immunotherapy.
    Akdis CA; Akdis M
    J Allergy Clin Immunol; 2011 Jan; 127(1):18-27; quiz 28-9. PubMed ID: 21211639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy: adherence based on timing and monitoring control visits.
    Vita D; Caminiti L; Ruggeri P; Pajno GB
    Allergy; 2010 May; 65(5):668-9. PubMed ID: 19845569
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is classical immunotherapy dead?
    Mösges R
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):167. PubMed ID: 20375879
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M; Akdis CA; Valenta R
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.